Brief: Abbisko Cayman Says CEO Purchased A Total Of 40,000 Ordinary Shares Of Co
13/03/2025 15:27
March 13 (Reuters) - Abbisko Cayman Ltd 2256.HK: CEO PURCHASED A TOTAL OF 40,000 ORDINARY SHARES OF CO AT AN AVERAGE PRICE OF HK$7.57 PER SHARE Further company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Medicine
See all newsChina's Abbisko jumps on positive clinical trial results for achondroplasia drug
Brief: Abbisko Cayman Says Unit Completes First Patient Dosing In Phase I Trial Of ABSK211
Brief: Abbisko Cayman Gets IND Clearance From FDA For Oral Small Molecule Pan-Kras Inhibitor ABSK211
HK-listed Abbisko hits 7-week peak on AstraZeneca tie-up
Brief: Abbisko Therapeutics And Astrazeneca Enter A Strategic Collaboration